Santhera Pharmaceuticals Aktie 

2,59EUR
-0,03EUR
-1,15%
18.06.2021
2,64CHF
-0,13CHF
-4,69%
18.06.2021
Hier für 0 Euro handeln mit
mehr Daten anzeigen
Werbung

Santhera Pharmaceuticals Aktien News

27.05.21
Santhera Pharmaceuticals Holdi : Santhera Publishes Agenda for its Annual General Meeting (Investegate)
20.05.21Press Release: Santhera Completes Capital Increase for Financing Arrangements (Dow Jones)
20.05.21
Santhera Pharmaceuticals Holdi : Santhera Completes Capital Increase for Financing Arrangements (Investegate)
07.05.21
Santhera Pharmaceuticals Holdi : Santhera Announces First Trading Day of New Convertible Bonds on SIX Swiss Exchange (Investegate)
04.05.21Press Release: Santhera Announces Settlement of -2- (Dow Jones)
04.05.21Press Release: Santhera Announces Settlement of Exchange Offer and Issuance of New Senior Unsecured Convertible Bonds due 2024 (Dow Jones)
30.04.21
Santhera Pharmaceuticals Holdi : Santhera Completes Capital Increases for Financing Arrangements (Investegate)
29.04.21
Santhera Pharmaceuticals Holdi : Santhera Reports 2020 Annual Results (Investegate)
28.04.21Press Release: Santhera and ReveraGen Announce -2- (Dow Jones)
28.04.21Press Release: Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy (Dow Jones)
28.04.21
Santhera Pharmaceuticals Holdi : Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy (Investegate)
23.04.21Press Release: Santhera to Announce 2020 Results on April 29, 2021 (Dow Jones)
20.04.21Press Release: Santhera Reports Interim Results -2- (Dow Jones)
20.04.21
Santhera Pharmaceuticals Holdi : Santhera Reports Interim Results on Convertible Bond Exchange Offer (Investegate)
06.04.21Press Release: Santhera Commences Convertible -2- (Dow Jones)
06.04.21Press Release: Santhera Commences Convertible Bond Exchange Offer and Continues to Seek Votes on the Bondholders' Resolution (Dow Jones)
06.04.21
Santhera Pharmaceuticals Holdi : Santhera Commences Convertible Bond Exchange Offer and Continues to Seek Votes on the Bondholders' Resolution (Investegate)
30.03.21Press Release: Santhera Completes Capital Increase for Financing Arrangements (Dow Jones)
30.03.21
Santhera Pharmaceuticals Holdi : Santhera Completes Capital Increase for Financing Arrangements (Investegate)
25.03.21Press Release: Santhera Launches Exchange Offer -2- (Dow Jones)
25.03.21Press Release: Santhera Launches Exchange Offer for its CHF 60 Million Convertible Bonds (Dow Jones)
25.03.21
Santhera Pharmaceuticals Holdi : Santhera Launches Exchange Offer for its CHF 60 Million Convertible Bonds (Investegate)
18.03.21Press Release: Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Meeting (Dow Jones)
18.03.21
Santhera Pharmaceuticals Holdi : Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting (Investegate)
10.03.21Press Release: Santhera Completes Capital Increase for Financing Arrangements (Dow Jones)
10.03.21
Santhera Pharmaceuticals Holdi : Santhera Completes Capital Increase for Financing Arrangements (Investegate)
09.03.21Press Release: Santhera Announces Results of Bondholders' Meeting (Dow Jones)
09.03.21
Santhera Pharmaceuticals Holdi : Santhera Announces Results of Bondholders’ Meeting (Investegate)
03.03.21Press Release: Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy (Dow Jones)
03.03.21
Santhera Pharmaceuticals Holdi : Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy (Investegate)
01.03.21Press Release: Santhera Announces Positive -2- (Dow Jones)
01.03.21Press Release: Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial (Dow Jones)
24.02.21Press Release: Santhera Calls Extraordinary General Meeting to Seek Approval for Proposed Strengthening of Capital Structure (Dow Jones)
24.02.21
Santhera Pharmaceuticals Holdi : Santhera Calls Extraordinary General Meeting to Seek Approval for Proposed Strengthening of Capital Structure (Investegate)
16.02.21Press Release: Santhera Announces Corporate -3- (Dow Jones)
16.02.21Press Release: Santhera Announces Corporate Update and Proposal to Strengthen Capital Structure (Dow Jones)
16.02.21
Santhera Pharmaceuticals Holdi : Santhera Announces Corporate Update and Proposal to Strengthen Capital Structure (Investegate)
05.02.21Press Release: Santhera Completes Capital Increase for Financing Arrangements (Dow Jones)
05.02.21
Santhera Pharmaceuticals Holdi : Santhera Completes Capital Increase for Financing Arrangements (Investegate)
25.11.20Press Release: Santhera Completes Capital Increase for Financing Arrangements (Dow Jones)
Seite: 1234567

Santhera Pharmaceuticals News

Santhera Pharmaceuticals News: auf dieser Seite finden Sie alle Santhera Pharmaceuticals News und Nachrichten zur Santhera Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Santhera Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Santhera Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung

Santhera Pharmaceuticals Peer Group News

Keine Nachrichten gefunden.
finanzen.net Brokerage
finanzen.net Zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln